Sir Steve Jackson elected as AACR Fellow in the Class of 2026
Publish date:
Share this page
Related News
See all news-
1M to advance AI powered personalised ovarian cancer care
19th February 2026
Researchers from our Brenton Group are part of an international team awarded the Global Ovarian Cancer Research Consortium’s inaugural AI Accelerator Grant.
Find out more -
New immune pathway offers treatment hope for childhood brain tumours
3rd February 2026
A newly discovered immune pathway could lead to gentler treatments for multiple childhood brain cancers, according to new research from our Gilbertson Group published today in Nature Genetics.
Find out more -
Targeting paused cells could improve chemotherapy for lung and ovarian cancers
3rd February 2026
New research published today in Nature Aging by scientists at the University of Cambridge sheds light on why some lung and ovarian cancers stop responding to chemotherapy, and how this resistance might one day be prevented.
Find out more
In their press release, the AACR noted that Professor Jackson was selected for his revered contributions to defining cellular DNA damage responses (DDR), including the discovery of DNA-dependent protein kinase (DNA-PK) and the core machinery of non-homologous end joining as well as for elucidating how ATM and ATR kinases, and key post-translational modifications preserve genome stability, work which has led to the development of DDR inhibitors and establishment of synthetic lethality as a transformative cancer treatment paradigm.
The mission of the Fellows of the AACR Academy is to recognize and honor extraordinary scientists whose groundbreaking contributions have driven significant innovation and progress in the fight against cancer. Fellows of the AACR Academy constitute a global brain trust of leading experts in cancer science and medicine, working to advance the AACR’s mission to prevent and cure all cancers through research, education, collaboration, communication, advocacy, and funding for cancer research.
Fellows of the AACR Academy are nominated and elected through a meticulous, multistep, peer-reviewed process that rigorously evaluates each candidate’s scientific achievements and contributions to the global cancer research community. Only those whose work has made a profound and lasting impact on cancer research and related fields are considered for election and induction into the AACR Academy.